63: Therapeutic Plasma Exchange During ECMO: Feasibility and Outcomes A Single-Centre Case Series

Background: The concurrent use of therapeutic plasma exchange (PLEX) and extracorporeal membrane oxygenation (ECMO) is uncommon and technically challenging, with limited data on safety and outcomes. PLEX may offer benefit in conditions driven by severe autoimmunity, hyperinflammation, or toxin overdose, which may co-exist with cardiopulmonary failure requiring ECMO. This case series elucidates our single-center experience with PLEX performed during ECMO support. Methods: We retrospectively reviewed all adult patients admitted to our cardiac thoracic intensive care unit in our hospital between December 2023 and June 2025 who underwent both ECMO and PLEX during the same admission. Demographic data, primary diagnoses, ECMO configuration, number and timing of PLEX sessions, and clinical outcomes were collected. Results: Four patients (median age 53 years, range 41–72; two female) underwent concomitant ECMO and PLEX. Indications for PLEX were thyroid storm (n=1), ANCA-associated vasculitis (n=2), and calcium channel blocker overdose (n=1). ECMO modalities included VA (n=2), VV (n=1), and VVA (n=1). PLEX was initiated within 72 hours of ECMO initiation in three patients. Three patients survived to hospital discharge (ANCA vasculitis with diffuse alveolar hemorrhage, Microscopic polyangiitis and CCB overdose), while one patient died from refractory shock (thyroid storm). No PLEX-related complications such as circuit clotting, hemolysis, or access issues were observed. In survivors, clinical and biochemical improvements facilitated ECMO decannulation and recovery. Limitations: This was a retrospective, small case series without a control group; causality between PLEX and outcome cannot be inferred. Conclusion: PLEX during ECMO runs is technically feasible and may provide additional therapeutic benefit in selected patients with autoimmune or toxin-mediated disease. Further prospective studies are warranted to define its role and optimal timing.

Authors

Institutions

Publication Details

Journal
ASAIO Journal
Published
2026-02-01
DOI
https://doi.org/10.1097/01.mat.0001180932.26790.64
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

63: Therapeutic Plasma Exchange During ECMO: Feasibility and Outcomes A Single-Centre Case Series

Ong Geok Seen, Aarthi Jayamani, Ramanathan Kollengode Ramaswamy, Subbian Senthil Kumar
ASAIO Journal
Mechanical Circulatory Support Devices
article

63: Therapeutic Plasma Exchange During ECMO: Feasibility and Outcomes A Single-Centre Case Series

Ong Geok Seen, Aarthi Jayamani, Ramanathan Kollengode Ramaswamy, Subbian Senthil Kumar
article en

Abstract

Background: The concurrent use of therapeutic plasma exchange (PLEX) and extracorporeal membrane oxygenation (ECMO) is uncommon and technically challenging, with limited data on safety and outcomes. PLEX may offer benefit in conditions driven by severe autoimmunity, hyperinflammation, or toxin overdose, which may co-exist with cardiopulmonary failure requiring ECMO. This case series elucidates our single-center experience with PLEX performed during ECMO support. Methods: We retrospectively reviewed all adult patients admitted to our cardiac thoracic intensive care unit in our hospital between December 2023 and June 2025 who underwent both ECMO and PLEX during the same admission. Demographic data, primary diagnoses, ECMO configuration, number and timing of PLEX sessions, and clinical outcomes were collected. Results: Four patients (median age 53 years, range 41–72; two female) underwent concomitant ECMO and PLEX. Indications for PLEX were thyroid storm (n=1), ANCA-associated vasculitis (n=2), and calcium channel blocker overdose (n=1). ECMO modalities included VA (n=2), VV (n=1), and VVA (n=1). PLEX was initiated within 72 hours of ECMO initiation in three patients. Three patients survived to hospital discharge (ANCA vasculitis with diffuse alveolar hemorrhage, Microscopic polyangiitis and CCB overdose), while one patient died from refractory shock (thyroid storm). No PLEX-related complications such as circuit clotting, hemolysis, or access issues were observed. In survivors, clinical and biochemical improvements facilitated ECMO decannulation and recovery. Limitations: This was a retrospective, small case series without a control group; causality between PLEX and outcome cannot be inferred. Conclusion: PLEX during ECMO runs is technically feasible and may provide additional therapeutic benefit in selected patients with autoimmune or toxin-mediated disease. Further prospective studies are warranted to define its role and optimal timing.

ASAIO JournalVol. 72(Supplement 1)
National University Hospital (SG)
Good health and well-being
Openalex Percentile: Top 67%
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.